---
title: Calysta
slug: calysta
qid: 
snapshot: enwiki-001359352942
content_hash: 
license: CC BY-SA 4.0
source: https://en.wikipedia.org/w/index.php?oldid=1359352942
tags: [115619803, 22906783, 23147661, 23603337, 24043274, 24745107, 26095571, 26220375, 26748027, 42161628, 5284565, 7403311, 90431561]
---

# Calysta

> [!note] Provenance
> Snapshot `enwiki-001359352942` · content root `…`
> Derived from <https://en.wikipedia.org/w/index.php?oldid=1359352942> · Licensed CC BY-SA 4.0

Calysta is a privately held biotechnology company based in California that develops and commercializes microbial protein ingredients through gas-fermentation technology for use in animal feed and other food applications. Calysta uses methanotrophic bacteria to ferment methane into single-cell protein ingredients designed for aquaculture and livestock feed applications. It also uses other food ingredients. Beginning in 2016, Calysta had operated a demonstration plant in Teesside, England, that used methanotroph bacteria to convert methane into FeedKind® single cell protein under a UK government grant. The product received approval for inclusion in fish and livestock feed in the European Union. The facility was later decommissioned as the company shifted away from pilot-scale operations. Calysta was founded in 2012, based on technology developed by scientists associated with DNA2.0 (now ATUM), a US synthetic biology company. Calysta secured venture funding to commercialize its methane-to-protein technology.

Calysta is a privately held biotechnology company based in California that develops and commercializes microbial protein ingredients through gas-fermentation technology for use in animal feed and other food applications. Calysta uses methanotrophic bacteria to ferment methane into single-cell protein ingredients designed for aquaculture and livestock feed applications. It also uses other food ingredients. Beginning in 2016, Calysta had operated a demonstration plant in Teesside, England, that used methanotroph bacteria to convert methane into FeedKind® single cell protein under a UK government grant. The product received approval for inclusion in fish and livestock feed in the European Union. The facility was later decommissioned as the company shifted away from pilot-scale operations. Calysta was founded in 2012, based on technology developed by scientists associated with DNA2.0 (now ATUM), a US synthetic biology company. Calysta secured venture funding to commercialize its methane-to-protein technology.
